Ex vivo-generated erythroblasts represent alternative transfusion products. However, inclusion of bovine components in media used for their growth precludes clinical use, highlighting the importance of developing culture media based on pharmaceutical grade reagents. In addition, because adult blood generates ex vivo lower numbers of erythroblasts than cord blood, cord blood has been proposed as the source of choice for ex vivo erythroblast production. To clarify the potential of adult blood to generate erythroblasts ex vivo, experiments were designed to identify growth factors [stem cell factor (SCF), interleukin-3 (IL-3), erythropoietin (EPO), and/or thrombopoietin (TPO)] and the optimal concentration and addition schedule of hormones (dexamethasone and estradiol) sustaining maximal erythroid amplification from adult blood mononuclear cells (MNC) using media with serum previously defined as human erythroid massive amplification culture (HEMA ser ). Adult MNC stimulated with SCF and IL-3 in combination with EPO generated a 6-12fold increase in erythroid cells while TPO was ineffective. Dexamethasone and estradiol (both at 10 −6 M) exerted partially overlapping but nonredundant functions. Dexamethasone was indispensable in the first 10 days of culture while estradiol was required from day 10 on. The growth factor and hormone combinations identified in HEMA ser were then used to formulate a media composed of dialyzed pharmaceutical grade human albumin, human albumin-lipid liposomes, and iron-saturated recombinant human tranferrin (HEMA def ). HEMA def sustained erythroid amplification as efficiently as HEMA ser for cord blood MNC and 10-fold higher than HEMA ser for adult blood MNC. In fact, the numbers of erythroblasts generated in HEMA def by adult MNC were similar to those generated by cord blood MNC. In conclusion, this study identifies growth factors, hormone combinations, and human protein-based media that allow similar levels of ex vivo erythroid expansion from adult and cord blood MNC, paving the way to evaluate adult blood as a source of ex vivoexpanded erythroblasts for transfusion. 453 454 MIGLIACCIO ET AL.
INTRODUCTION
cord blood unit cultured under these conditions may produce ex vivo erythroid cells sufficient for two to three transfusions (i.e., two to three times 2.7 × 10 12 erythroid Stem cell factor (SCF), in combination with interleukin-3 (IL-3) and erythropoietin (EPO), sustains unil-cells) ( 37) . To be used as an alternative transfusion product, however, the media used to generate these cells ineage erythroid maturation in culture (34, 58) . The further addition of agonists of the glucocorticoid (dexa-require better definition. In particular, the combination of growth factors, the relative role played by DXM and methasone, DXM) (54) and estrogen (β-estradiol, ES) (17, 27, 31, 39) receptor delays differentiation, allowing ES in the expansion process, and the identification of pharmaceutical grade reagents to replace proteins of ani-the generation of a greater number of erythroblasts (EBs) (ϳ10 9 -10 10 EBs from 10 6 adult or cord blood-mal origin in the media, as recommended by the FDA guidance for cell therapy products (16) , are areas of in-derived CD34 + cells, respectively). On the basis of the number of CD34 + cells contained in an average cord tensive investigation (30, 37) . The generation of EBs from hematopoietic progenitor blood collection, investigators have calculated that one cells includes a first commitment phase, usually occur-leukemia cells (52). Steroids (ES, progesterone, and testosterone) also increase the numbers of erythroid bursts ring in the first 4-10 days of culture, which generates erythroid precursors (EPCs). In the second phase of cul-in cultures of human MNC (48) . However, these hormones do not affect DMSO-induced differentiation (52), ture, EPCs mature into EBs, which ultimately cease to proliferate and begin to mature. The final number of suggesting different modes of action. Glucocorticoids and estrogens mediate their biologi-EBs generated by each hematopoietic progenitor by the end of this process is regulated by the growth factors/ cal effects by forming a complex with the respective receptors that migrate to the nucleus to bind and acti-hormones to which the cells are exposed and that control the speed with which they progress along the maturation vate/repress specific target genes (53) . The observation that the genes targeted by glucocorticoids are a subset cascade. The receptors expressed by hematopoietic cells as they mature predict that at least partially different of those regulated by SCF (25) suggests that these hormones may be primarily effective on SCF-sensitive growth factor/hormone combinations may control the speed of differentiation at different stages of the process CD34 + /EPC cells. In erythroid cells, the ES receptor forms a complex with the transcription factor GATA1, (24). The generation of EPCs from early progenitor cells, identified in humans by the expression of the leading to its inactivation (6) . Because maturation of EPCs into EBs is concentration dependent with respect CD34 marker (CD34 + cells), is strictly controlled by the combination of SCF and EPO (33) . Other growth fac-to GATA1 (38) , ES may retard transition from EPCs and EBs, retaining EPCs in proliferation longer. In addi-tors, however, such as GM-CSF, IL-3, thrombopoietin (TPO), insulin-like growth factor-1 (IGF-1), and prosta-tion, ES may increase the proliferation potential of EPCs by upregulating the levels of telomerase activity in these glandin (PGE) (29, 33) may synergize SCF and EPO by increasing the number of progenitor cells recruited in cells (7) . Telomerase controls the elongation of the chromosome telomeres, a structure reduced after each cell the process and/or the number of EBs generated by each progenitor cell as their presence increases both the num-cycle that measures the number of divisions that a cell may undergo (22) . These results suggest that DXM and ber and size of erythroid bursts obtained in culture. These growth factors may therefore increase the number ES may, respectively, control amplification of early SCF-sensitive, and late (GATA1 and telomere length of EPCs generated by CD34 + cells. IL-3 and GM-CSF bind a heterodimeric receptor composed of a common limited) erythroid cells. Ex vivo EB expansion is apparently higher in cul-signaling (β-chain) and a specific binding (α-chain) subunit encoded by genes closely linked on the pseudoau-tures seeded with CD34 + cells than in those using MNC (30) . However, because considerable numbers of CD34 + tosomal region of the X-Y chromosomes (24). Because these receptors are coexpressed, the biological activities cells are lost during the purification procedure, MNC cultures generate absolute numbers of EBs much higher of IL-3 and GM-CSF are partially redundant (24). By contrast, Mpl, the TPO receptor, is expressed on a large than those obtained in cultures of CD34 + cells (30) . Because MNC contain accessory cells, DXM and ES may spectrum of hematopoietic cells that includes stem cells and cells expressing the EPO receptor (24), suggesting increase the number of EBs generated in culture seeded with MNC also by activating/repressing, accessory cell that TPO, by recruiting stem cells, may generate committed erythroid progenitors more efficiently than EPO. populations, possibly at concentrations different from those active on erythroid cells. DXM, in fact, suppresses On the basis of these considerations, TPO is included in some growth factor formulations for ex vivo expansion the proliferation of T cells (5) that release growth factors that inhibit EB proliferation (9). On the other hand, the of EBs (1, 12) .
The generation of high numbers of EBs in liquid cul-increase in the number of erythroid bursts observed in cultures stimulated with ES is dependent on the presence ture of human CD34 + cells requires the presence both of glucorticoids and estrogens (3, 55) . This discovery was of monocytes, which likely release growth factors when stimulated by these hormones (10). The mode of action, based on the extensively described effect of glucocorticoids and steroids on erythroid differentiation in clinical direct and/or indirect, and the type of cells, early or late erythroid cells or accessory cells, targeted by DXM and conditions (13, 19) , in mouse mutants (3) , and in culture models of erythroid differentiation (4, 18, 48, 52) . Whether ES determine at which stage of erythroid expansion culture these two hormones must be added to exert their these hormones exert direct or indirect effects on erythroid differentiation and the cell type (immature vs. maximal effects. We have previously identified culture conditions, de-mature cells) targeted is still unclear. Glucocorticoids (prednisone, hydrocortisone, and its synthetic analogue, fined as human erythroid massive amplification (HEMA) culture, that sustain the generation of great numbers DXM) increase the number of erythroid bursts generated in vitro by human mononuclear cells (MNC) (18) and (10 8-10 ) of EBs from MNC of either cord blood or adult blood (31) . The media used in HEMA cultures contain block DMSO-induced differentiation of Friend erythro-fetal bovine serum (HEMA ser ) and are not clinical grade.
TRF, Sigma-Aldrich), a mixture of lipids (cholesterol, from egg yolks, Cat. No. C3045, Sigma-Aldrich, and Serum-derived media replacing FBS with its active components (albumin, iron-saturated tranferrin, and lipids) soybean lecithin, Cat. No. P3644, Sigma-Aldrich), and a mixture of five nutrients (MIX5). Iron-saturated h-for the growth of human erythroid bursts were first established in 1987 (32) . Although these serum-free for-TRF (1% w/v final concentration) was prepared dissolving 1 g of protein in 3.2 ml of FeCl 3 (7.9 × 10 −3 M in mulations are still based on bovine-derived proteins, the development of these media generated information on HCl 10 −3 M) in 11.2 ml of IMDM, pH 7.2. Lipids (3% w/v final concentration) were prepared as liposome so-the requirements of EBs in culture that can be exploited to formulate equivalent media composed of reagents of lution using HSA instead of BSA as previously described (50) . The final cholesterol (dissolved in 0.4 ml human origin (HEMA def ) and to test their efficacy. of absolute ethanol) and soybean lecithin concentrations MATERIALS AND METHODS are 400 µg and 1.2 mg/ml, respectively. MIX5 contains human recombinant insulin, sodium pyruvate, nucleo-Human Subjects sides, trace elements, and L-glutamine (each one as Peripheral blood buffy coat was prepared from nor-100×) and was used at 5% v/v. Human recombinant inmal adult blood donations collected at the blood center sulin (Merck KGaA, Darmstadt, Germany, endotoxin of "La Sapienza" University (Rome, Italy). Cord blood content <0.25) was dissolved with HCl (0.1 N) at a conwas obtained from full-term pregnancies at the time of centration of 40 mg/ml and diluted with IMDM to 1 mg/ delivery at the Public Hospital of Pescara (Italy). Speciml and pH adjusted with NaOH (0.1 M). Sodium pyrumens were collected and provided for this study accordvate (10 included "lipids cholesterol rich" from adult bovine se-Louis, MO, USA), and 10% v/v dimethylsulphoxide rum (LCR, Cat. No. L4646, Sigma-Aldrich, cholesterol (DMSO, Sigma-Aldrich). The samples in cryopreservacontent 9.0-11.0 g/L and protein content 15.0-25.0 g/ tive media were placed in a Nalgene Cryobox (Thermo L, ≤6.0 EU/mg cholesterol), and Lipomax (1% v/v, In-Fisher Scientific, Roskilde, Denmark) at −80°C overvitrogen S.R.L., Milan, Italy). night and then stored in liquid nitrogen (35) .
Detoxification of Bovine and Human Serum Albumin Media Used for Ex Vivo Expansion
BSA was deionized according to published methods HEMA ser Medium. This medium, described elsewere (30, 50) . Briefly, 50 g of BSA was dissolved in 125 ml of (31), is composed of IMDM supplemented with FBS tissue culture grade water at 4°C without stirring. When (20% v/v), detoxified bovine serum albumin (BSA, 15% solubilized, 20 g of resin (Cat. No. AG-501-X8, Biow/v purified fraction V, Sigma-Aldrich, see below), L-Rad, Hercules, CA, USA) or equivalent amounts of glutamine (1 ng/ml, 200 mM, Euroclone SPA, Milan, Amberlite AG mixed resin (Type mB-1, SERVA Elec-Italy), antibiotics (10,000 U/ml penicillin G sodium, trophoresis GmbH, Heidelberg, Germany) were added 10,000 U/ml streptomycin sulfate, and 25 µg/ml fungito the mixture and maintained overnight at 4°C without zone, PSF, Lonza Group Ltd), and β-mercaptoetanol (βstirring. The decanted solution was diluted 1:1 with 2× Mpt, 7.5 × 10 −5 M, Sigma-Aldrich).
IMDM-PSF without NaHCO 3 and the pH adjusted to 7.3 (final BSA concentration 15% w/v). Human albumin HEMA def Medium. This medium contains the same components of the serum-deprived media described by (25% HSA, Baxter International Inc., Deerfield, IL, USA) was detoxified using a double dialysis process Migliaccio and Migliaccio (32) except that albumin and other bovine proteins are replaced with human proteins.
during which the preparation was first dialyzed overnight a +4°C against endotoxin-free USP water (1:80 v/ Briefly, the media is composed of IMDM supplemented with detoxified human serum albumin (HSA, 10% v/v, v) and then against an equal volume of IMDM. Both BSA and HSA solutions were sterilized by filtration see below), β-Mpt, human iron-saturated transferrin (h-(0.45 µm, Millipore, Billerica, MA, USA) and endotoxin Inc., Chester, VA, USA) equipped with a Coolsnap Video camera (Roper Scientific, Munich, Germany). contamination excluded with the Lymulus Amebocyte Lysate assay (Lonza Group Ltd) and pretested for their Immunophenotypic Analysis efficacy to sustain the growth of human erythroid bursts Cell antigenic profile was analyzed by flow cytomein semisolid assay against a standard (Stem Cell Techtry. For any sample, 5 × 10 5 cells were suspended in nology, Vancouver, Canada, http://www.stemcell.com).
Ca 2+ Mg 2+ -free phosphate-buffered saline, supplemented The final solutions were stored at −20°C for 6 months.
with 0.5% BSA, 2 mM EDTA, 0.01% NaN 3 , and labeled with the following anti-human antibodies: isothiocya-Expansion of Human EBs nate (FITC)-conjugated CD36 (anti-thrombospondin re-For each experiment, 50 × 10 6 adult MNCs were ceptor), or isothiocyanate (FITC)-conjugated CD61 thawed and washed twice in IMDM plus 1% BSA or (anti-megakaryocytes) and phycoerythrin (PE)-conju-HSA to remove residual DMSO. Cells were kept overgated CD235a (anti-glycophorin A), or appropriate isonight in IMDM, 5% FBS, 4% BSA (or 9% HSA), 1% type controls (all from Immunotech, Milan, Italy). All L-glutamine/PSF/β-Mpt and supplemented with SCF the antibodies were incubated for 30 min in the dark on and IL-3 (1 ng/ml each) at 37°C in a fully humidified ice. Propidium iodide was used to exclude dead cells (5 5% CO 2 /air atmosphere (Forma Scientific, Marietta, µg/ml, Invitrogen). Stained cells were analyzed with a OH, USA). The following day (considered day 0 cul-FACSAria (Becton Dickinson and Company, Franklin ture), viable MNCs were counted, washed once with Lakes, NJ, USA) and results analyzed using FlowJo IMDM plus 1% FBS (or HSA), and seeded at 10 6 cells/ software (version 7.2.5, Tree Star Inc., Ashland, OR, ml in HEMA ser or HEMA def medium and stimulated with USA). Size determinations were obtained by comparing human SCF (SCF, 10 ng/ml, Amgen, Thousand Oaks, the mean forward scatter of the cells with those ex-CA, USA), human EPO (3 U/ml, Neorecormon, Auckpressed by calibration beads (6-15 µm in diameter; land, New Zeland), and human IL-3 (1 ng/ml, Bio-Flow Cytometry Size Calibration Kit, Molecular Probes, source, San Jose, CA, USA). DXM and ES (both from Eugene, OR, USA), as previously described (47). Sigma-Aldrich) were added at 10 −6 M final concentration, unless otherwise stated. Selected experiments were Statistical Analysis performed in the presence of human TPO (50 ng/ml of Cell amplifications are presented as fold increase PEG-MGDF, Kirin Brewery, Gunma, Japan). The cells (number of cells at day X/number of cells at day 0), were cultured at 37°C in a fully humidified 5% CO 2 /air unless otherwise stated. Results are the mean ± SD of atmosphere for 17-21 days. During the culture, the cell multiple experiments. Statistical analysis was performed concentration was monitored on a regular basis and the by paired t-test with the Origin 6.1 software for Wincultures supplemented with fresh media to maintain the dows (Microcal Software Inc, Northampton, MA, USA). concentration below 10 6 cells/ml. DXM and ES (0.5% v/v) were freshly added to the culture every 48 h. RESULTS
Growth Factor Requirements for Massive Ex Vivo Differentiation of Ex Vivo-Generated EBs
Amplification of Human Adult Erythroblasts EBs generated in HEMA cultures were induced to
The growth factors necessary for optimal ex vivo EB mature by an additional 4 days of culture in media conexpansion in the absence of hormones were identified taining EPO (3 U/ml) and recombinant human insulin by culturing adult blood MNC for 14 days in HEMA ser (10 ng/ml). media stimulated with SCF, IL-3, and EPO, alone and in combinations (Fig. 1 ). The generation of cells in cul-Cell Count and Viability Assessment ture was expressed as fold increase (FI), a ratio that un-Cell numbers and viability were assessed using manderestimates EB expansion because it does not take into ual techniques and trypan blue dye exclusion (dilution account that EPCs are rare among MNCs and that their 1:1) every 48 h. frequency among progenies obtained with different growth factors may vary.
Morphological Assessment
After 10-14 days of culture, hematopoietic cells were observed in the presence of all the growth factor combi-Cell morphology was analyzed according to standard criteria on cytocentrifuged (Cytospine3, Shandon, Ast-nations analyzed. The cells generated in cultures were usually of multiple lineages but predominantly macro-moor, England) smears stained with May-Grünwald-Giemsa. Microscopic evaluations were performed using phages and lymphocytes, with the exception of cultures stimulated with SCF + EPO and SCF + IL-3 + EPO, in cytocentrifuged preparations of 3 × 10 5 cells per sample with a ZEISS AXIOSKOPE light microscope (Carl Zeiss which the cells were mostly EBs at various stages of maturation (Fig. 1B) . The combination that generated tures is still below input values and does not include morphologically recognizable EBs, and from day 10 on the highest, although still modest, numbers of EBs (FI > 2) was SCF + IL-3 + EPO ( Fig. 1A) and was therefore when morphologically recognizable EBs begin to accumulate. We hypothesized that a hormone whose role chosen to stimulate expansion of EBs in the other experiments.
would be mainly to enhance commitment and to stimulate accessory cells would be more active in the first 10 Dexamethasone and Estradiol Exert Distinctive, days of culture while a hormone that would retard EB but Partially Overlapping, Effects on Ex Vivo maturation would be more effective at later time points.
Expansion of Human Adult Erythroblasts
Hence, DXM and ES, alone or in combinations, were added for the first 10 days and then withdrawn from day The relative impact of DXM and ES on the expansion of EBs in vitro was assessed by comparing the number 10 on ( Fig. 3 ). To take into account the donor variability in the response to hormones, these experiments were re-of EBs generated in HEMA ser culture of adult MNC where the concentration of DXM or ES was maintained peated with MNCs obtained from 10 separate donors.
In spite of the great variability of results obtained at 10 −6 M while varying the concentration of the other hormone within ranges previously reported to be active with multiple donors, control experiments confirmed that ES, although ineffective alone in generating high in vitro (10 −7 -10 −5 M) over a period of 19 days. Because these cultures were stimulated with SCF + IL-3 + EPO, numbers of EBs in culture, did consistently synergize with DXM in generating greater numbers of EBs over it is not surprising that almost all of the cells detected from day 7 on were EBs (Fig. 2 and data not shown).
time (results in cultures stimulated with DXM alone and DXM + ES are statistically different by paired t-test, Addition of DXM alone (10 −6 M) increased EB expansion from the twofold increase observed between p < 0.05). Retarded addition experiments demonstrated that the presence of DXM was essential in the first 10 day 7 and 14 in cultures stimulated with growth factors alone (Fig. 1A) to sixfold ( Fig. 2A ). Further addition of days of culture to observe amplification of EBs. Cultures initiated for the first 10 days in the absence of hormones ES increased the number of EBs generated over time in a concentration-dependent fashion up to a concentration ( Fig. 3B ) or with ES alone (Fig. 3D ) did not generate high numbers of EBs when stimulated with hormones, of 10 −6 M with no further increase. In the presence of DXM alone, maximal numbers of EBs were observed at alone or in combination, at later time points. On the other hand, cultures initiated with DXM + ES generated day 14 while in cultures stimulated with DXM and ES the numbers of EBs increased up to day 17 ( Fig. 2A) . similar numbers of EBs when stimulated with only one hormone, either ES or DXM, for the last 7 days (Fig. EBs obtained in the presence of DXM and ES (both 10 −6 M) were more homogenous in terms of maturation stage, 3C). However, the highest number of EBs were generated in cultures stimulated with DXM alone for the first and more resistant to physical stress than those obtained with higher DXM concentrations (see the morphology 10 days and then switched to ES for the last 7 days. In fact, in these cultures, the number of EBs did not reach and the density of the cells in the cytospin preparations presented in Fig. 2C ). By contrast, ES alone (10 −6 M) a plateau at day 14 but continued to increase for the duration of the experiments (day 21) ( Fig. 3D ). did not increase the number of EBs generated in culture above those observed with growth factors alone ( Fig. These results indicate that the presence of DXM is essential for optimal expansion during the first 10 days 2B). The further addition of DXM increased the number of EBs generated in those cultures up to a concentration of culture. Both DXM and ES sustain amplification of EBs from day 10 of culture, although ES is more potent of 10 −6 M, above which the cells no longer increased in number and became fragile to physical stress (Fig. 2B than (and may even be antagonistic to) DXM at these later time points. and D).
In conclusion, the concentration of DXM and ES that Megaloblastic Appearance of Adult Erythroblasts sustains maximal generation of EBs in HEMA ser cultures Generated Ex Vivo Under HEMA ser Conditions of adult MNC is 10 −6 M.
The observation that ES alone did not further in-EBs obtained in cultures stimulated with DXM and ES have a megaloblastic morphology (Fig. 2) . Flow cy-creased the numbers of EBs generated in culture above that obtained with growth factors suggested that the two tometry studies were performed to quantify the size of the EBs obtained in these cultures (Fig. 4) . Ex vivo-hormones may control different stages of the maturation process. To clarify this point, experiments were per-generated EBs from adult MNCs range in size from 30 to 50 µm (i.e., a size three times greater than that of the formed to determine the time at which DXM and ES exerted their maximal effects (Fig. 3 ). In these experi-corresponding cells generated in vivo). When EBs were cultured in differentiation media containing only EPO, ments, HEMA ser cultures were divided into two periods: day 0-10, when the number of cells present in the cul-the size decreased from 40.1 ± 1.4 to 28.5 ± 2.0, 21.2 ± The total number of EBs generated ex vivo may be increased by favoring proliferation of early progenitor culture in EPO are still macrocytic (11.6 vs. 8 µm of adult normocytic red cells), although smaller than fetal cells before commitment to the erythroid lineage becomes irreversible. Because TPO has been reported to red cells (12.5 µm) (40) . The size of enucleated red cells obtained from these ex vivo-expanded red cells has not increase the number of EBs generated ex vivo from adult CD34 + cells (42) , experiments were undertaken to been measured because of their low frequency in maturation cultures without a feeder layer (17, 36) . determine whether TPO would increase the numbers of EBs generated under HEMA ser conditions. In these ex-Therefore, the megaloblastic appearance of EBs generated in HEMA culture is reversible when cells mature periments, the numbers of EBs generated in HEMA ser cultures of adult MNCs stimulated with SCF + IL-3 in in EPO, acquiring a size similar to that of cells generated in vivo. combination with either EPO or TPO were compared ( Fig. 5) . By contrast to the great numbers of EBs gener-SCF + IL-3 + TPO for 17 days and switched to SCF + IL-3 in combination with either TPO or EPO for 5 addi-ated in cultures stimulated with SCF + IL-3 + EPO, very few cells were observed in the presence of SCF + IL-3 tional days. No increase in total cell numbers was observed under either condition (Fig. 5B ). In the delayed in combination with TPO ( Fig. 5A ). In addition, lymphocytes, which represented only 5-10% of the cells addition experiments, HEMA ser cultures were initiated with SCF + IL-3 + EPO for 17 days and then split into detectable after 13-17 days in cultures stimulated with EPO, were the predominant (46-60%) population in the cultures stimulated with SCF + IL-3 in combination with either EPO or TPO for 5 days. A sharp decrease parallel cultures stimulated with TPO (Table 1) .
Mpl, the receptor for TPO, has been reported to be (64% to 55% of day 0) in total cell number was observed between 17 and 20 days in cultures supplemented expressed on human bipotent megakaryocytic/erythroid progenitor cells (14). It could be argued, therefore, that with SCF + IL-3 + TPO while the number of EBs observed in those stimulated with SCF + IL-3 + EPO re-TPO may have expanded the erythroid progenitors but that these cells failed to mature because of lack of EPO. mained almost constant (Fig. 5C ). By flow cytometry analyses, the majority of the cells that survived in the It is also possible that erythroid cells generated in the presence of SCF + IL-3 + EPO could be induced to presence of TPO in these experiments were erythroid (CD36 + CD235a + ) whereas those expressing the mega-grow in the presence of TPO. To test these hypotheses, TPO withdrawal ( Fig. 5B ) and delayed addition ( Fig. karyocytic marker CD61 were <2% in all cases (data not shown). 5C) experiments were performed. In the withdrawal experiments, HEMA ser cultures where stimulated with These results suggest that the presence of the hor- mones DXM and ES interferes with the ability of ery-ture and favors its adsorption by the cells. HSA-based liposomes can be prepared according to methods pub-throid cells to respond to TPO and that maturation along the megakaryocyte pathway under HEMA ser conditions lished for BSA (32, 50) , and human recombinant transferrin (h-Trf) is commercially available and can be satu-is minimal. rated with iron according to published methods (32, 50) .
Development of HEMA def Media
In preliminary experiments, the requirement for efficient lipid and iron delivery systems for ex vivo EBs Previous attempts to use ex vivo-expanded human cells have identified possible adverse events linked to amplification under HEMA conditions was evaluated by comparing the numbers of EBs generated in BSA-based the use of bovine proteins in culture. Subjects treated with repeated administration of the ex vivo-expanded serum-free cultures supplemented or not with HSAbased liposomes (chol-lecithin) and h-Tfr (Fig. 6 ). Com-cells developed an arthus-like reaction to components of the FBS present in the medium used for cell production mercial sources of lipids of bovine origin were included in the analyses, for comparison. Preliminary concentra-(46).
Serum-free medium optimized for in vitro differentia-tion/response curves and delayed addition experiments conducted with the commercial FBS-derived prepara-tion of human erythroid progenitors has been previously established by replacing FBS with its individual active tions (Lipomax and LCR) confirmed that lipids, although toxic at high concentrations, improve the numbers (FI = components (albumin, transferrin, lipids, and other additives including vitamins and cofactors) (32) . In prelimi-3 vs. 7 in lipid-repleted and lipid-supplemented cultures, respectively) and the morphology, especially from day nary experiments, this serum-free medium was capable of supporting ex vivo expansion of EBs from adult and 17 on, of EBs generated in serum-deprived medium ( Fig. 6A, and data not shown). HSA-based liposomes cord blood MNC as well as HEMA ser (data not shown), identifying the active components of the FBS that had were as efficient as the commercial lipid preparations in sustaining ex vivo EB expansion in these cultures ( Fig.  to be replaced with equivalent elements of human origin in the formulation of the HEMA def medium.
6A). The further addition of h-Trf did not increase the number (results not shown) but improved the morphol-Appropriate lipid and iron delivery represent critical aspects of the development of serum-repleted media.
ogy of the EBs generated at day 17 ( Fig. 6B, and data not shown), which became similar to that of cells gener-Commercial sources of albumin are contaminated with lipids. In addition, albumin has the property to bind iron ated in HEMA ser (compare Fig. 6B and Fig. 2C, D) . Because of its central role in the preparation of the in the media and to deliver it to the cells. Therefore, a deficiency of lipids and iron does not limit cell growth other components of the medium, the most important component to be humanized was albumin. Commercial under serum-free conditions but albumin-based cell delivery of these compounds may not be sufficient for sources of clinical grade human albumin approved for human use as plasma volume expanders were obtained massive EBs amplification. Lipids can be solubilized in water as liposomes, artificial vesicles whose membrane from Baxter (5% and 25% w/v albumin USP). These solutions are prepared from pooled blood donor plasma bilayer is composed of cholesterol and phospholipids that, in the absence of apolipoprotein E, are slowly ab-screened/treated for infectious agents. In preliminary experiments, these human albumin solutions were toxic sorbed by cultured cells by diffusion. The inclusion of albumin in the lipid bilayer stabilizes the liposome struc-both in semisolid and liquid culture of primary human hematopoietic progenitors (data not shown). We hypoth-blood ( Fig. 7) . In cultures of cord blood MNCs, HEMA def sustained generation of erythroid cells in numbers con-esized that the toxicity was due to the presence of low molecular weight additives required to stabilize the albu-sistently slightly higher (by 1.5-fold) than those obtained with HEMA ser media. In cultures initiated with 1 × 10 6 min in solution to avoid flocculation and devised a strategy to remove these additives by treating the preparation cord blood MNCs, at day 17, ϳ300 × 10 6 and ϳ500 × 10 6 EBs were obtained in HEMA ser and HEMA def me-with a double dialysis process (see Materials and Methods). Dialyzed human albumin was then used to prepare dium, respectively. By flow cytometry, EBs can be divided into three the human equivalent of the bovine serum-free medium previously described (32) , dubbed HEMA def . A series of classes of maturation (40): class 1, CD36 high CD235a − (CFU-E and proerythroblasts); class 2, CD36 high CD experiments was performed to compare the efficacy of HEMA ser and HEMA def in supporting ex vivo expansion 235a high (basophilic-polychromatic erythroblasts), and class 3, CD36 low CD235a high (orthochromatic erythro-of EBs from MNCs obtained from cord blood and adult blasts). In both media, the maturation profile of the cells believe the superior amplification of adult EBs observed under HEMA def conditions is likely due to the fact that obtained from cord blood MNCs remained predominantly immature (>60% of CD36 + CD235a low-med cells) up in these cultures adult EBs remain immature. While the EBs obtained in both cultures were mostly immature at to day 17 of culture ( Fig. 7A ). By contrast, in experiments performed with adult blood MNCs, HEMA def me-day 7, in HEMA ser they matured by day 9, in spite of the presence of hormones (>50% CD36 − CD235a high ) while dia was clearly superior to HEMA ser media in sustaining EB amplification (Fig. 7B) . Although similar numbers remaining immature (>60% CD36 + CD235 − low ) until day 19 in HEMA def (Fig. 6B) . Interestingly, the number and of EBs were generated in the two culture media until day 14 (ϳ150 × 10 6 EBs), from day 14 on the number morphology of EBs obtained at days 17-19 under HEMA def conditions from cord blood and adult blood of EBs obtained in HEMA ser culture remained constant while that obtained in HEMA def media continued to in-MNC were similar.
These results indicate that, after detoxification, clini-crease up to day 19, reaching the value of >750 × 10 6 cells generated per each original 10 6 MNC cultured. We cal grade human albumin can be used to prepare a cul- Figure 7 . Comparison of the total number and maturation profile of human erythroblasts expanded from cord blood (A) or adult blood (B) MNCs in HEMA ser or HEMA def media. The maturation profile was defined by FACS analyses on the basis of CD36 and CD235a expression (40) . Results are representative of those obtained in three separate cord blood and adult blood experiments, each with a different donor.
ture medium that generates numbers of human EBs at (49) . On the other hand, the activated ES receptor forms a complex with GATA1 that makes this transcription least similar to those obtained in HEMA ser medium. In the case of adult blood MNCs, the use of HEMA def al-factor transcriptionally inactive (6) . It is therefore possible that DXM and ES in combination may decrease too lowed the generation of numbers of EBs similar to those previously achievable with cord blood MNCs. much the level of GATA1 activity, inducing apoptosis and decreasing the number of ex vivo-generated EBs.
DISCUSSION
Alternatively, the greater effects of ES on amplification of EBs may, instead, be related to the fact that ES, in The aim of this study was to define the growth factors, hormones, and media required for ex vivo amplifi-addition to controlling GATA1 activity, might also stimulate telomerase activity in these cells (7) . cation of EBs from adult MNCs. The results obtained confirm SCF, IL-3, and EPO as the growth factor com-It has been reported that the levels of telomerase activity increase during EB maturation (43) and that vari-bination that sustains unilineage amplification of EBs. They also confirm that both DXM and ES at a concen-ability in both the length of the telomere (45) and the levels of telomerase expression (2) correlate with the tration of 10 −6 M are required for optimal amplifications to occur. Surprisingly, TPO was ineffective in sustaining numbers of EBs expanded from CD34 + cells obtained from different cord blood units. Therefore, optimal gen-significant levels of EB generation in cultures containing hormones.
eration of EBs under HEMA conditions may require sequential addition of DXM and ES. However, further ex-Delayed addition/replacement experiments indicated that DXM and ES exerted their maximal effect at differ-periments are necessary to identify the optimal time at which the culture should be switched from DXM to ES ent time points in culture. The presence of DXM was necessary during the first 10 days of culture, when few for maximal amplification to occur. These kinetics studies must also evaluate whether genetic polymorphisms EBs were recognizable (31) . This result confirms microarray studies indicating that the glucocorticoid receptor at the DXM (11) and ES (7) receptor loci may alter the response of ex vivo-generated EBs to these hormones. may promote EB expansion by regulating the expression of a subset of those genes under the control of EPO and Finally, a humanized media (HEMA def ) was identified for ex vivo amplification of EBs from adult MNCs. Un-SCF (30) . In addition to its direct role on EB maturation, DXM may promote EB generation indirectly by block-der these conditions, adult MNCs generated EBs that remained immature longer and generated greater num-ing the proliferation of T cells (5) , which are particularly numerous at the beginning of the culture, reducing the bers of EBs, numbers as high as those previously obtained under HEMA ser conditions only from cord blood release of growth inhibitors secreted by these cells. However, during these first 10 days, ES alone was not MNCs. The reason for the higher numbers of adult EBs obtained under HEMA def is not known. One of the differ-effective and did not interfere with the effects exerted by DXM. ences between cord and adult blood MNCs is the activation status of T cells. Adult T cells are more mature and After day 10, when the cultures were composed mostly of EBs, DXM and/or ES were necessary to gen-react more readily in vitro to antigens than cord blood T cells (41) . It is therefore possible that antigens present erate great numbers of EBs. DXM and ES in combination generated numbers of EBs greater that those gener-on bovine proteins, including albumin, may activate adult T cells in spite of the presence of DXM. It is con-ated by DXM alone but inferior to those generated by ES alone. These results indicate that later in culture the ceivable then, that replacement of bovine proteins with human protein, in addition to preventing immune-medi-two hormones have overlapping but distinctive mechanisms of action. A common target may be represented ated clinical complications, may allow the generation of transfusion products from adult blood donations. Be-by GATA1, a transcription factor that exerts a concentration-dependent effect on EB cell fate (38) . High levels cause of their capacity to generate high numbers of EBs ex vivo, cord blood MNCs and CD34 + cells have been of GATA1 activity accelerate maturation (56) while low levels induce apoptosis (26) . The generation of great up to now considered as the progenitor source of choice for ex vivo generation of erythroid transfusion products numbers of EBs under HEMA conditions is, therefore, dependent on culture conditions that, by maintaining (30, 37) . The observation that adult MNCs generate under HEMA def conditions numbers of EBs similar to those constant levels of GATA1 activity, allow the cells to proliferate. Under HEMA conditions, EPO, by repress-generated by cord blood MNCs (this manuscript) paves the way to consider discarded MNCs from blood dona-ing caspase-mediated GATA1 degradation, increases the levels of GATA1 activity and promotes maturation (44).
tions as a source of progenitor cells for ex vivo-generated transfusion products. Both DXM and ES reduce GATA1 activity. DXM has been reported to induce rapid GATA1 degradation in Using HEMA def media, MNCs from adult blood donations generated EB numbers similar to those generated MEL cells (8) and in ex vivo-generated human EBs 
